Minghui Pharmaceutical (hangzhou) Ltd

This study is testing an ointment called MH004 for people with non-segmental vitiligo, a condition that causes loss of skin color. About 156 adolescents and adults will apply the ointment or a placebo cream for 24 weeks, followed by a longer safety period. The main goal is to see…

This early-stage clinical trial is testing a new drug called MHB036C in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The study will enroll about 200…

This study is testing a new drug called MHB039A for people with advanced solid tumors that haven't responded to standard treatments. Researchers will first find the safest dose, then test how well the drug works against specific cancer types. The main goals are to check side effe…